Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Moodys
Chubb
US Department of Justice
Julphar
Citi
Teva
Federal Trade Commission
Argus Health

Generated: November 22, 2018

DrugPatentWatch Database Preview

Tentative Approvals for: ibandronate sodium

« Back to Dashboard

ibandronate sodium Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Teva Parenteral ibandronate sodium 079194 1MG INJECTABLE; INJECTION
Cobalt Labs Inc ibandronate sodium 079002 2.5MG TABLET; ORAL
Applicant Generic Name NDA Strength Dosage Form

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
UBS
Covington
McKinsey
Cerilliant
US Army
AstraZeneca
US Department of Justice
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.